maklogo
Market Research Report

Global Peripheral IV Cannula Market Insights, Size, and Forecast By Product Type (Over-the-Needle Cannula, Under-the-Skin Cannula, Butterfly Cannula, Multilumen Cannula), By End Use (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers), By Application (Fluid Administration, Blood Administration, Medication Administration, Nutritional Support), By Material (Plastic, Stainless Steel, Silicone), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:18598
Published Date:Jan 2026
No. of Pages:246
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Peripheral IV Cannula Market is projected to grow from USD 5.8 Billion in 2025 to USD 10.9 Billion by 2035, reflecting a compound annual growth rate of 6.4% from 2026 through 2035. The market encompasses devices vital for intravenous access, facilitating drug administration, fluid delivery, and blood sampling. A major driver for this growth is the increasing prevalence of chronic diseases globally, necessitating frequent intravenous therapies. The rising number of surgical procedures, an aging population more susceptible to various ailments, and the growing demand for minimally invasive procedures further propel market expansion. Technological advancements leading to safer, more comfortable, and longer-dwelling cannulas are also contributing significantly to market growth. Conversely, market growth is somewhat restrained by the risk of needlestick injuries and associated infections, as well as the availability of alternative drug delivery methods. However, opportunities abound in developing nations with improving healthcare infrastructure and increasing awareness about advanced medical devices. The market is segmented by Application, Product Type, Material, and End Use, providing a granular view of diverse product offerings and their utilization across the healthcare spectrum.

Global Peripheral IV Cannula Market Value (USD Billion) Analysis, 2025-2035

maklogo
6.4%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

North America holds the dominant share in the peripheral IV cannula market, primarily due to its well-established healthcare infrastructure, high healthcare expenditure, and the presence of leading market players. The region benefits from early adoption of advanced medical technologies and a high rate of chronic disease management requiring frequent intravenous access. Hospitals represent the leading end-use segment, driven by the high volume of patient admissions for various medical conditions, surgical interventions, and emergency care requiring IV access. This segment's dominance underscores the critical role of peripheral IV cannulas in inpatient settings. Key market trends include the shift towards safety-engineered cannulas to minimize needlestick injuries and the increasing adoption of materials that reduce the risk of phlebitis and other complications.

Asia Pacific is anticipated to be the fastest growing region in the peripheral IV cannula market. This rapid growth is attributed to improving economic conditions, expanding healthcare access, and a burgeoning patient population in countries like China and India. The increasing incidence of chronic diseases, coupled with a growing focus on enhancing healthcare facilities, is fueling demand for advanced medical devices in the region. Leading market players such as Nipro, Vygon, Abbott Laboratories, Halyard Health, BD, Smiths Medical, AngioDynamics, Cardinal Health, Terumo, and B. Braun are actively engaged in strategic initiatives. These strategies include product innovation, geographical expansion, mergers and acquisitions, and collaborations to strengthen their market position and cater to the evolving needs of healthcare providers globally. The focus on developing cannulas with improved biocompatibility and extended dwell times represents a significant area of research and development for these companies, aiming to enhance patient comfort and safety while reducing healthcare costs associated with frequent cannula replacements.

Quick Stats

  • Market Size (2025):

    USD 5.8 Billion

  • Projected Market Size (2035):

    USD 10.9 Billion

  • Leading Segment:

    Hospitals (45.8% Share)

  • Dominant Region (2025):

    North America (38.2% Share)

  • CAGR (2026-2035):

    6.4%

What is Peripheral IV Cannula?

A Peripheral IV Cannula is a small, flexible tube inserted into a peripheral vein, typically in the arm or hand. It creates a temporary access point to the bloodstream without puncturing the vein repeatedly. The cannula allows for the administration of fluids, medications, blood products, and nutrients directly into the patient's circulatory system. It consists of a plastic catheter over a needle, with the needle removed after insertion, leaving the catheter in place. Its significance lies in providing a rapid, safe, and efficient method for delivering vital therapies, crucial for various medical treatments, emergency care, and diagnostic procedures.

What are the Trends in Global Peripheral IV Cannula Market

  • Smart Cannula Innovations Driving Market Expansion

  • Eco Friendly Materials Revolutionizing Cannula Design

  • Enhanced Safety Features Boosting Market Adoption

  • Home Healthcare Demand Fueling Cannula Growth

Smart Cannula Innovations Driving Market Expansion

Smart cannulas, integrating sensors and enhanced features, are revolutionizing the global peripheral IV cannula market. These innovations improve insertion accuracy, reduce complications like phlebitis, and enable real time monitoring. This technological leap drives adoption by healthcare providers seeking improved patient outcomes and reduced healthcare costs, fostering significant market expansion.

Eco Friendly Materials Revolutionizing Cannula Design

Eco friendly materials are transforming cannula design in the global market. Manufacturers are adopting sustainable polymers, biodegradable components, and recycled plastics to reduce environmental impact. This revolution addresses mounting pressure for greener medical devices, offering safer, more sustainable options for patients and healthcare providers while enhancing biocompatibility and disposability features.

Enhanced Safety Features Boosting Market Adoption

Safety innovations are driving Peripheral IV Cannula market growth. Manufacturers are integrating features like needle stick prevention and improved catheter securement. These enhancements address healthcare worker safety concerns and patient comfort, leading to wider acceptance and increased adoption in clinical settings. The enhanced safety reduces complications and training time, boosting demand significantly.

Home Healthcare Demand Fueling Cannula Growth

Aging populations and chronic conditions increase home healthcare needs. Patients receiving care at home frequently require intravenous access for medication and hydration. This consistent demand for IV therapy in non hospital settings directly drives the increased utilization and sales of peripheral IV cannulas, as these devices are essential for home based treatments.

What are the Key Drivers Shaping the Global Peripheral IV Cannula Market

  • Rising Incidence of Chronic Diseases and Surgeries

  • Advancements in Cannula Technology and Materials

  • Growing Geriatric Population and Associated Healthcare Needs

  • Increasing Demand for Minimally Invasive Procedures

Rising Incidence of Chronic Diseases and Surgeries

An increasing prevalence of chronic conditions like cancer and cardiovascular diseases necessitates frequent venipuncture for medication and fluid administration. The escalating number of surgical procedures, often requiring intravenous access for anesthesia and post operative care, further drives demand for peripheral IV cannulas globally. This growing patient pool reliant on intravenous therapy directly expands the market.

Advancements in Cannula Technology and Materials

Improved cannula designs, including slimmer profiles and easier insertion mechanisms, reduce patient discomfort and complications. Biocompatible materials like advanced polymers minimize infection risks and allergic reactions. These innovations enhance safety, efficacy, and patient outcomes, making cannulas more appealing to healthcare providers globally and thus driving market expansion.

Growing Geriatric Population and Associated Healthcare Needs

An aging global population presents a significant driver for the peripheral IV cannula market. Elderly individuals often require frequent hospitalizations, surgeries, and long term care due to chronic diseases and age related health issues. These medical interventions necessitate intravenous access for medication administration, fluid delivery, and blood sampling. The increasing number of geriatric patients directly translates to higher demand for peripheral IV cannulas, fueling market expansion.

Increasing Demand for Minimally Invasive Procedures

Patients and healthcare providers increasingly favor minimally invasive procedures due to reduced pain quicker recovery and fewer complications. This trend directly boosts the demand for peripheral IV cannulas as they are essential for accessing the bloodstream during these less invasive interventions. Their use facilitates medication delivery fluid administration and blood sampling efficiently supporting the growing preference for such medical approaches across various specialties.

Global Peripheral IV Cannula Market Restraints

Stringent Regulatory Approval Processes for New Cannula Technologies

Introducing innovative cannula technologies demands navigating extensive and costly regulatory pathways. Manufacturers face prolonged development timelines and substantial investment in clinical trials to meet rigorous safety and efficacy standards set by health authorities worldwide. This stringent approval process delays market entry for novel devices, hindering innovation and limiting the pace at which advanced cannulas become available to patients and healthcare providers. The complexity and duration of these approvals significantly challenge new product introduction.

High Cost of Advanced Peripheral IV Cannulas Limiting Adoption in Developing Regions

High manufacturing costs for advanced peripheral IV cannulas pose a significant barrier to their widespread adoption in developing regions. Limited healthcare budgets and financial constraints make it challenging for these countries to invest in premium devices. This disparity in affordability restricts access to potentially superior cannula technologies, hindering improved patient care and broader market penetration in these crucial areas, despite their clinical benefits.

Global Peripheral IV Cannula Market Opportunities

Advanced Cannula Designs for Optimized First-Stick Success and Reduced Complications

Developing advanced cannula designs presents a significant opportunity to enhance first-stick success, reducing patient discomfort and procedure time globally. Innovations like improved tip geometries, enhanced visualization, and better catheter materials minimize insertion failures and related complications such as infections or phlebitis. This addresses critical unmet needs for healthcare providers seeking efficiency and improved patient safety. Manufacturers who innovate to achieve superior clinical outcomes and user friendly designs will capture substantial market share, especially in rapidly growing regions where demand for reliable IV access solutions is escalating. This leads to reduced healthcare costs and better overall patient experiences.

Leveraging Antimicrobial Coatings and Smart Features for Enhanced Patient Safety and Extended Dwell Time

This opportunity involves integrating antimicrobial coatings onto peripheral IV cannulas, significantly reducing catheter related bloodstream infections. Concurrently, incorporating smart features like real time monitoring for phlebitis, occlusion, or dislodgement provides early alerts, drastically enhancing patient safety. These innovations facilitate extended dwell times for cannulas, minimizing painful reinsertions and improving patient comfort. This proactive approach elevates patient care standards, lessens healthcare costs, and drives market innovation globally.

Global Peripheral IV Cannula Market Segmentation Analysis

Key Market Segments

By Application

  • •Fluid Administration
  • •Blood Administration
  • •Medication Administration
  • •Nutritional Support

By Product Type

  • •Over-the-Needle Cannula
  • •Under-the-Skin Cannula
  • •Butterfly Cannula
  • •Multilumen Cannula

By Material

  • •Plastic
  • •Stainless Steel
  • •Silicone

By End Use

  • •Hospitals
  • •Clinics
  • •Home Healthcare
  • •Ambulatory Surgical Centers

Segment Share By Application

Share, By Application, 2025 (%)

  • Fluid Administration
  • Blood Administration
  • Medication Administration
  • Nutritional Support
maklogo
$5.8BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why are hospitals dominating the Global Peripheral IV Cannula Market?

Hospitals represent the largest segment in the market due to their extensive patient admissions for a wide array of medical conditions requiring intravenous access. These facilities manage critical care, surgical procedures, emergency services, and chronic disease management, all heavily relying on peripheral IV cannulas for medication, fluid, and blood administration. The sheer volume of patients, coupled with the need for immediate and continuous intravenous therapy across various departments, firmly establishes hospitals as the primary consumers of these essential medical devices.

Which product types are most widely adopted in the peripheral IV cannula market?

Over the Needle Cannulas are the most prevalent product type, largely due to their ease of insertion, versatility, and broad applicability across numerous medical scenarios. Their design allows for efficient intravenous access for fluid and medication delivery, making them a standard choice in emergency rooms, operating theaters, and general wards. While other types like butterfly or multilumen cannulas serve specific needs, the simplicity and effectiveness of over the needle designs drive their widespread adoption across various healthcare settings.

How do diverse applications influence the demand for peripheral IV cannulas?

The varied applications significantly drive market demand, reflecting the fundamental role of IV access in modern healthcare. Fluid administration, blood administration, medication administration, and nutritional support each require reliable peripheral venous access, creating a constant and high demand for cannulas. From rehydrating patients and delivering life saving blood transfusions to administering critical medications and providing essential nutrients, the indispensable nature of these applications ensures sustained and growing consumption of peripheral IV cannulas across the entire healthcare spectrum.

What Regulatory and Policy Factors Shape the Global Peripheral IV Cannula Market

The global peripheral IV cannula market operates under stringent regulatory frameworks. Key regions like North America, Europe, and Asia Pacific mandate approvals from bodies such as FDA, CE marking organizations, and national health authorities. Compliance with ISO 13485 quality management systems and device specific standards like ISO 10555 is crucial for market entry and product conformity. Post market surveillance, adverse event reporting, and rigorous quality control measures are universally enforced. Policies emphasizing patient safety, infection prevention protocols, and sharps injury prevention significantly influence product design and adoption. Unique Device Identification UDI systems are increasingly prevalent, enhancing traceability. Evolving regulations often drive innovations in safety features and biocompatibility. Harmonization efforts by IMDRF influence global standards, streamlining market access while maintaining high safety benchmarks.

What New Technologies are Shaping Global Peripheral IV Cannula Market?

Innovations in peripheral IV cannulas are transforming patient care and clinician efficiency. Next generation designs emphasize enhanced needle stick prevention and superior insertion technologies, significantly reducing complications. Advanced biocompatible materials are extending dwell times, minimizing frequent venipunctures and patient discomfort. The emergence of antimicrobial coated cannulas directly addresses catheter related bloodstream infections, improving patient outcomes. Smart cannulas, integrating sensor technology for real time placement feedback and patency monitoring, are also gaining traction. These technological advancements, including even smaller gauges for fragile veins and automation in insertion and monitoring, promise greater efficacy, improved safety, and substantial healthcare cost reductions globally, fueling significant market evolution.

Global Peripheral IV Cannula Market Regional Analysis

Global Peripheral IV Cannula Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

North America dominates the global peripheral IV cannula market, holding a substantial 38.2% share. This leadership position is driven by several factors, including advanced healthcare infrastructure, high adoption rates of advanced medical devices, and significant R&D investments. The region benefits from a strong presence of key market players, contributing to continuous product innovation and market expansion. Furthermore, increasing prevalence of chronic diseases and a growing elderly population further fuel market growth in North America, ensuring its continued prominence in the foreseeable future. Robust reimbursement policies and a focus on patient safety also contribute to the region's strong market performance.

Europe, a significant region in the peripheral IV cannula market, is characterized by its high healthcare expenditure and advanced medical infrastructure. The market here is driven by an aging population, rising chronic disease prevalence, and increasing surgical procedures. Stringent regulatory frameworks from bodies like the EMA emphasize patient safety and device quality, influencing product innovation towards advanced, safer cannulas (e.g., those with safety mechanisms). Key players focus on product differentiation, mergers, and acquisitions to maintain market share amidst intense competition and evolving healthcare needs across Western and Eastern European countries.

The Asia Pacific Peripheral IV Cannula market is the fastest-growing region, projected at a 7.9% CAGR. This growth is propelled by increasing healthcare infrastructure development and a rising prevalence of chronic diseases across countries like China, India, and Japan. Improved access to healthcare, a growing aging population requiring frequent medical interventions, and rising disposable incomes further contribute to market expansion. Investments in advanced medical technologies and expanding healthcare expenditure in developing nations are key drivers. Local manufacturers are also emerging, intensifying competition and driving innovation in the region.

Latin America's peripheral IV cannula market is expanding due to increased healthcare spending and improved access. Brazil and Mexico dominate, driven by large patient populations and rising chronic disease prevalence. Key trends include demand for safety-engineered devices and lower gauge cannulas for specialized procedures. However, price sensitivity and varying regulatory landscapes pose challenges. Local manufacturing is limited, making the region reliant on imports. Growth opportunities lie in enhancing product training and developing solutions tailored to specific regional clinical needs and economic constraints, particularly in smaller economies and public healthcare systems seeking cost-effective alternatives while maintaining quality.

Middle East & Africa (MEA) peripheral IV cannula market exhibits robust growth, driven by increasing healthcare expenditure and improving medical infrastructure. The region benefits from rising awareness about safe injection practices and adoption of advanced cannula technologies, including safety-initiated and closed-system devices. Key drivers include a high prevalence of chronic diseases necessitating intravenous treatments and expanding hospital networks in countries like Saudi Arabia, UAE, and South Africa. Challenges include pricing pressures and the dominance of conventional cannulas. However, a growing focus on infection control and patient safety continues to stimulate demand for innovative, high-value cannulas across the MEA region.

Top Countries Overview

The US peripheral IV cannula market is robust yet fragmented. Innovation drives competition with new materials and designs. Consolidation is occurring as larger players acquire smaller ones. Increased focus on safety and infection control impacts product development and market share among manufacturers.

China is a key player in the global peripheral IV cannula market. Domestic production is increasing to meet local demand and global exports are expanding. Challenges include intense competition and the need for continuous innovation. The market is driven by healthcare expansion and rising patient numbers.

India’s peripheral IV cannula market is growing driven by healthcare infrastructure and patient volumes. Domestic manufacturing and global players compete, focusing on cost effectiveness and quality. Regulatory landscape and increasing awareness of infection control influence market dynamics.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical stability and healthcare policy shifts profoundly influence the peripheral IV cannula market. Increased global healthcare spending, driven by rising chronic disease prevalence in emerging economies, fosters market expansion. However, supply chain disruptions due to geopolitical tensions or trade disputes, particularly impacting raw material availability and manufacturing hubs, pose significant headwinds. Regulatory convergence and standardization efforts across regions could streamline market entry for new innovations, while protectionist trade policies might fragment it.

Macroeconomic conditions directly impact market dynamics. Economic growth in developing nations expands access to modern healthcare, fueling demand for cannulas. Conversely, recessions or austerity measures in developed economies can lead to reduced hospital budgets, impacting procurement volumes and shifting preferences towards lower cost alternatives. Inflationary pressures on manufacturing and distribution costs could translate to higher product prices, potentially dampening adoption, especially in price sensitive markets.

Recent Developments

  • March 2025

    BD launched its next-generation safety peripheral IV cannula (PIVC) featuring enhanced visualization technology. This new product aims to improve first-stick success rates and reduce complications for healthcare professionals.

  • September 2024

    Cardinal Health announced a strategic partnership with a leading AI-driven imaging company to integrate advanced vein visualization technology into its PIVC insertion kits. This collaboration seeks to improve patient safety and comfort during cannula placement by enhancing the ability to locate suitable veins.

  • January 2025

    Terumo successfully acquired a smaller innovator specializing in antimicrobial-coated PIVCs, expanding its portfolio of infection-prevention products. This acquisition strengthens Terumo's position in the high-growth segment of cannulas designed to reduce the risk of catheter-related bloodstream infections.

  • November 2024

    Smiths Medical introduced a new line of PIVCs specifically designed for pediatric and neonatal patients, featuring smaller gauges and specialized materials for delicate veins. This product launch addresses a critical unmet need in pediatric care, offering safer and more comfortable venipuncture solutions for the youngest patients.

  • April 2025

    B. Braun initiated a major strategic initiative to invest in automated PIVC insertion devices, aiming to enhance efficiency and standardize insertion procedures across healthcare settings. This move reflects a broader industry trend towards automation in medical procedures to reduce human error and improve patient outcomes.

Key Players Analysis

Key players like B. Braun, BD, and Terumo dominate the Global Peripheral IV Cannula Market, driving innovation and market expansion. These companies are pivotal in developing advanced cannula technologies, including safety features, improved materials, and user friendly designs, significantly contributing to patient comfort and reduced complications. Strategic initiatives such as mergers, acquisitions, and collaborations with healthcare providers are common, enhancing their product portfolios and market reach. The increasing demand for safer medical devices, rising surgical procedures, and growing awareness about infection prevention are primary market growth drivers benefiting these industry leaders. Their continuous investment in research and development ensures a competitive edge and sustained market leadership.

List of Key Companies:

  1. Nipro
  2. Vygon
  3. Abbott Laboratories
  4. Halyard Health
  5. BD
  6. Smiths Medical
  7. AngioDynamics
  8. Cardinal Health
  9. Terumo
  10. B. Braun
  11. Medtronic
  12. Boston Scientific

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 5.8 Billion
Forecast Value (2035)USD 10.9 Billion
CAGR (2026-2035)6.4%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Application:
    • •Fluid Administration
    • •Blood Administration
    • •Medication Administration
    • •Nutritional Support
  • By Product Type:
    • •Over-the-Needle Cannula
    • •Under-the-Skin Cannula
    • •Butterfly Cannula
    • •Multilumen Cannula
  • By Material:
    • •Plastic
    • •Stainless Steel
    • •Silicone
  • By End Use:
    • •Hospitals
    • •Clinics
    • •Home Healthcare
    • •Ambulatory Surgical Centers
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Peripheral IV Cannula Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.1.1. Fluid Administration
5.1.2. Blood Administration
5.1.3. Medication Administration
5.1.4. Nutritional Support
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
5.2.1. Over-the-Needle Cannula
5.2.2. Under-the-Skin Cannula
5.2.3. Butterfly Cannula
5.2.4. Multilumen Cannula
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
5.3.1. Plastic
5.3.2. Stainless Steel
5.3.3. Silicone
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.4.1. Hospitals
5.4.2. Clinics
5.4.3. Home Healthcare
5.4.4. Ambulatory Surgical Centers
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Peripheral IV Cannula Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.1.1. Fluid Administration
6.1.2. Blood Administration
6.1.3. Medication Administration
6.1.4. Nutritional Support
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
6.2.1. Over-the-Needle Cannula
6.2.2. Under-the-Skin Cannula
6.2.3. Butterfly Cannula
6.2.4. Multilumen Cannula
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
6.3.1. Plastic
6.3.2. Stainless Steel
6.3.3. Silicone
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.4.1. Hospitals
6.4.2. Clinics
6.4.3. Home Healthcare
6.4.4. Ambulatory Surgical Centers
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Peripheral IV Cannula Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.1.1. Fluid Administration
7.1.2. Blood Administration
7.1.3. Medication Administration
7.1.4. Nutritional Support
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
7.2.1. Over-the-Needle Cannula
7.2.2. Under-the-Skin Cannula
7.2.3. Butterfly Cannula
7.2.4. Multilumen Cannula
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
7.3.1. Plastic
7.3.2. Stainless Steel
7.3.3. Silicone
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Home Healthcare
7.4.4. Ambulatory Surgical Centers
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Peripheral IV Cannula Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.1.1. Fluid Administration
8.1.2. Blood Administration
8.1.3. Medication Administration
8.1.4. Nutritional Support
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
8.2.1. Over-the-Needle Cannula
8.2.2. Under-the-Skin Cannula
8.2.3. Butterfly Cannula
8.2.4. Multilumen Cannula
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
8.3.1. Plastic
8.3.2. Stainless Steel
8.3.3. Silicone
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Home Healthcare
8.4.4. Ambulatory Surgical Centers
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Peripheral IV Cannula Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.1.1. Fluid Administration
9.1.2. Blood Administration
9.1.3. Medication Administration
9.1.4. Nutritional Support
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
9.2.1. Over-the-Needle Cannula
9.2.2. Under-the-Skin Cannula
9.2.3. Butterfly Cannula
9.2.4. Multilumen Cannula
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
9.3.1. Plastic
9.3.2. Stainless Steel
9.3.3. Silicone
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home Healthcare
9.4.4. Ambulatory Surgical Centers
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Peripheral IV Cannula Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.1.1. Fluid Administration
10.1.2. Blood Administration
10.1.3. Medication Administration
10.1.4. Nutritional Support
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
10.2.1. Over-the-Needle Cannula
10.2.2. Under-the-Skin Cannula
10.2.3. Butterfly Cannula
10.2.4. Multilumen Cannula
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
10.3.1. Plastic
10.3.2. Stainless Steel
10.3.3. Silicone
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Healthcare
10.4.4. Ambulatory Surgical Centers
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Nipro
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Vygon
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Abbott Laboratories
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Halyard Health
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. BD
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Smiths Medical
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. AngioDynamics
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Cardinal Health
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Terumo
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. B. Braun
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Medtronic
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Boston Scientific
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 2: Global Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 3: Global Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 4: Global Peripheral IV Cannula Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 5: Global Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 7: North America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 8: North America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 9: North America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 10: North America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 12: Europe Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 13: Europe Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 14: Europe Peripheral IV Cannula Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 15: Europe Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 17: Asia Pacific Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 18: Asia Pacific Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 19: Asia Pacific Peripheral IV Cannula Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 20: Asia Pacific Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 22: Latin America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 23: Latin America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 24: Latin America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 25: Latin America Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 27: Middle East & Africa Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 28: Middle East & Africa Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 29: Middle East & Africa Peripheral IV Cannula Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 30: Middle East & Africa Peripheral IV Cannula Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Healthcare Market Research

Explore comprehensive market research reports covering all aspects of the Healthcare industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;